Dai-ichi Life (TYO:8750) has secured regulatory approval to arrange leveraged buyout financing, a first for a Japanese life insurer, enabling it to structure and price deal loans amid rising domestic M&A activity, Nikkei Asia reported on Saturday.
The insurer's subsidiary can now originate Leveraged Buyouts (LBO) lending opportunities, collecting arrangement fees while setting terms and sizing, with collateral backed by the acquired firm's assets and cash flows, the news daily said.
This allows acquirers to execute transactions with limited upfront capital, addressing growing demand for deal-related funding in Japan's active buyout market, the publication said.
Dai-ichi Life didn't immediately respond to MT Newswire's request for comment.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)